Argentina · Delayed Price · Currency is ARS ShockWave Medical Statistics
Total Valuation
AbbVie has a market cap or net worth of ARS 470.01 trillion. The enterprise value is 558.46 trillion.
| Market Cap | 470.01T |
| Enterprise Value | 558.46T |
Important Dates
The last earnings date was Friday, July 25, 2025.
| Earnings Date | Jul 25, 2025 |
| Ex-Dividend Date | Jul 15, 2025 |
Share Statistics
| Current Share Class | n/a |
| Shares Outstanding | n/a |
| Shares Change (YoY) | +0.03% |
| Shares Change (QoQ) | -0.06% |
| Owned by Insiders (%) | n/a |
| Owned by Institutions (%) | n/a |
| Float | 1.76B |
Valuation Ratios
The trailing PE ratio is 105.94 and the forward PE ratio is 14.88.
| PE Ratio | 105.94 |
| Forward PE | 14.88 |
| PS Ratio | 6.76 |
| PB Ratio | 269.77 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | 125.87 |
| EV / Sales | 7.02 |
| EV / EBITDA | 14.58 |
| EV / EBIT | 21.01 |
| EV / FCF | n/a |
Financial Position
| Current Ratio | n/a |
| Quick Ratio | n/a |
| Debt / Equity | 47.90 |
| Debt / EBITDA | 2.49 |
| Debt / FCF | n/a |
| Interest Coverage | 6.14 |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | n/a |
| Return on Invested Capital (ROIC) | 16.33% |
| Return on Capital Employed (ROCE) | n/a |
| Revenue Per Employee | 1.26B |
| Profits Per Employee | 80.67M |
| Employee Count | 55,000 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | -883.05B |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +7.01% in the last 52 weeks.
| Beta (5Y) | n/a |
| 52-Week Price Change | +7.01% |
| 50-Day Moving Average | 23,254.00 |
| 200-Day Moving Average | 22,564.88 |
| Relative Strength Index (RSI) | 74.08 |
| Average Volume (20 Days) | 1,318 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | 2.44 |
Income Statement
In the last 12 months, AbbVie had revenue of ARS 69.51 trillion and earned 4.44 trillion in profits. Earnings per share was 2,502.76.
| Revenue | 69.51T |
| Gross Profit | 49.37T |
| Operating Income | 23.24T |
| Pretax Income | 3.61T |
| Net Income | 4.44T |
| EBITDA | 33.08T |
| EBIT | 23.24T |
| Earnings Per Share (EPS) | 2,502.76 |
Balance Sheet
The company has 6.17 trillion in cash and 83.45 trillion in debt, giving a net cash position of -77,279.36 billion.
| Cash & Cash Equivalents | 6.17T |
| Total Debt | 83.45T |
| Net Cash | -77,279.36B |
| Net Cash Per Share | n/a |
| Equity (Book Value) | 1.74T |
| Book Value Per Share | 958.06 |
| Working Capital | n/a |
Cash Flow
| Operating Cash Flow | n/a |
| Capital Expenditures | n/a |
| Free Cash Flow | n/a |
| FCF Per Share | n/a |
Margins
Gross margin is 71.03%, with operating and profit margins of 33.43% and 6.45%.
| Gross Margin | 71.03% |
| Operating Margin | 33.43% |
| Pretax Margin | 5.19% |
| Profit Margin | 6.45% |
| EBITDA Margin | 47.59% |
| EBIT Margin | 33.43% |
| FCF Margin | n/a |
Dividends & Yields
This stock pays an annual dividend of 534.09, which amounts to a dividend yield of 2.00%.
| Dividend Per Share | 534.09 |
| Dividend Yield | 2.00% |
| Dividend Growth (YoY) | 74.17% |
| Years of Dividend Growth | 4 |
| Payout Ratio | n/a |
| Buyback Yield | -0.03% |
| Shareholder Yield | 1.97% |
| Earnings Yield | 0.94% |
| FCF Yield | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 2 |